124 related articles for article (PubMed ID: 3001976)
41. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques.
Puusaari I; Heikkonen J; Kivelä T
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045
[TBL] [Abstract][Full Text] [Related]
42. Proton beam irradiation of uveal melanomas at Paul Scherrer Institute (former SIN).
Zografos L; Perret C; Egger E; Gailloud C; Greiner R
Strahlenther Onkol; 1990 Jan; 166(1):114. PubMed ID: 2154044
[No Abstract] [Full Text] [Related]
43. Intraoperative localization of tantalum markers for proton beam radiation of choroidal melanoma by an opto-electronic navigation system: a novel technique.
Amstutz CA; Bechrakis NE; Foerster MH; Heufelder J; Kowal JH
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1361-6. PubMed ID: 21665382
[TBL] [Abstract][Full Text] [Related]
44. Review of current protocols for protontherapy in USA.
Krengli M; Liebsch NJ; Hug EB; Orecchia R
Tumori; 1998; 84(2):209-16. PubMed ID: 9620247
[TBL] [Abstract][Full Text] [Related]
45. Conservative treatment of uveal melanoma: probability of eye retention after proton treatment.
Munzenrider JE; Gragoudas ES; Seddon JM; Sisterson J; McNulty P; Birnbaum S; Johnson K; Austin-Seymour M; Slater J; Goitein MM
Int J Radiat Oncol Biol Phys; 1988 Sep; 15(3):553-8. PubMed ID: 2843486
[TBL] [Abstract][Full Text] [Related]
46. Proton beam therapy of uveal melanomas.
Gragoudas ES
Arch Ophthalmol; 1986 Mar; 104(3):349-51. PubMed ID: 3006647
[No Abstract] [Full Text] [Related]
47. Proton radiobiology, radiosurgery and radiotherapy.
Raju MR
Int J Radiat Biol; 1995 Mar; 67(3):237-59. PubMed ID: 7897273
[TBL] [Abstract][Full Text] [Related]
48. Practice Patterns Analysis of Ocular Proton Therapy Centers: The International OPTIC Survey.
Hrbacek J; Mishra KK; Kacperek A; Dendale R; Nauraye C; Auger M; Herault J; Daftari IK; Trofimov AV; Shih HA; Chen YE; Denker A; Heufelder J; Horwacik T; Swakoń J; Hoehr C; Duzenli C; Pica A; Goudjil F; Mazal A; Thariat J; Weber DC
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):336-343. PubMed ID: 27084651
[TBL] [Abstract][Full Text] [Related]
49. Prospects for proton-beam radiotherapy.
Nahum AE; Dearnaley DP; Steel GG
Eur J Cancer; 1994; 30A(10):1577-83. PubMed ID: 7833122
[TBL] [Abstract][Full Text] [Related]
50. Proton beam irradiation of uveal melanomas. Results of 5 1/2-year study.
Gragoudas ES; Goitein M; Verhey L; Munzenreider J; Urie M; Suit H; Koehler A
Arch Ophthalmol; 1982 Jun; 100(6):928-34. PubMed ID: 6284097
[TBL] [Abstract][Full Text] [Related]
51. What are the potential benefits of using proton therapy in Taiwanese cancer patients?
Kao WH; Shen YL; Hong JH
Biomed J; 2015; 38(5):391-8. PubMed ID: 25768324
[TBL] [Abstract][Full Text] [Related]
52. Proton therapy for base of skull chordoma: a report for the Royal College of Radiologists. The Proton Therapy Working Party.
Clin Oncol (R Coll Radiol); 2000; 12(2):75-9. PubMed ID: 10853743
[TBL] [Abstract][Full Text] [Related]
53. Clinical applications of proton therapy. Experiences and ongoing studies.
Habrand JL; Schlienger P; Schwartz L; Pontvert D; Lenir-Cohen-Solal C; Helfre S; Haie C; Mazal A; Cosset JM
Radiat Environ Biophys; 1995 Mar; 34(1):41-4. PubMed ID: 7604159
[TBL] [Abstract][Full Text] [Related]
54. Proton therapy for the management of uveal melanoma and other ocular tumors.
Mishra KK; Daftari IK
Chin Clin Oncol; 2016 Aug; 5(4):50. PubMed ID: 27558251
[TBL] [Abstract][Full Text] [Related]
55. Proton beam therapy for uveal melanoma.
Lawton AW
Ophthalmology; 1989 Jan; 96(1):138-9. PubMed ID: 2537482
[No Abstract] [Full Text] [Related]
56. Proton therapy for head and neck cancer: rationale, potential indications, practical considerations, and current clinical evidence.
Mendenhall NP; Malyapa RS; Su Z; Yeung D; Mendenhall WM; Li Z
Acta Oncol; 2011 Aug; 50(6):763-71. PubMed ID: 21767172
[TBL] [Abstract][Full Text] [Related]
57. Comments on "Ocular proton therapy, pencil beam scanning high energy proton therapy or stereotactic radiotherapy for uveal melanoma; an in silico study".
Elmali A; Yazici G
Cancer Radiother; 2023 May; 27(3):233-234. PubMed ID: 37080854
[No Abstract] [Full Text] [Related]
58. Proton therapy in ophthalmology: status report and problems encountered.
Chauvel P; Iborra-Brassart N; Courdi A; Hérault J; Teissier E; Pignol JP; Bondiau PY
Bull Cancer Radiother; 1996; 83 Suppl():215s-8s. PubMed ID: 8949783
[TBL] [Abstract][Full Text] [Related]
59. Experimental study on the fractionation schedule for proton irradiation of uveal melanoma.
Wollensak G; Zografos L; Perret C; Egger E; Fritz-Niggli H
Graefes Arch Clin Exp Ophthalmol; 1990; 228(6):562-8. PubMed ID: 2265772
[TBL] [Abstract][Full Text] [Related]
60. Clinical applications of proton therapy.
Habrand JL; Schlienger P; Schwartz L; Pontvert D; Lenir-Cohen-Solal C; Helfre S; Mammar H; Haie-Meder C; Ferrand R; Mazal A
Bull Cancer Radiother; 1996; 83 Suppl():207s-11s. PubMed ID: 8949781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
